EUVIMEDEUVIMED entdecken
Crossref

Gi Signaling Does Not Differentiate Hallucinogenic from Nonhallucinogenic 5-HT2A Receptor Agonists

Cassandra J Hatzipantelis iD, David E Olson iD

ACS Chemical Neuroscience · 04.11.2026 · 17 (21) · 3458-3461

DOI: 10.1021/acschemneuro.6c00743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 17.10.2026. Verfasst von Cassandra J Hatzipantelis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Davis, Davis, California95616, United States. Hauptthemen laut MEDLINE: Hallucinogens, Serotonin 5-HT2 Receptor Agonists, Signal Transduction, Receptor, Serotonin, 5-HT2A. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A recent publication by Xu et al. suggests that Gi activation following 5-HT2AR stimulation differentiates hallucinogenic from nonhallucinogenic agonists. Here, we reanalyze the author’s source data to demonstrate that Gi activation is less predictive of hallucinogenic potential than canonical effectors of 5-HT2AR signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensSerotonin 5-HT2 Receptor AgonistsSignal TransductionReceptor, Serotonin, 5-HT2AHumansAnimals

Stichwörter der Autor:innen

5-HT2ARGi signalinghallucinogenpsychedelic

Substanzen

HallucinogensSerotonin 5-HT2 Receptor AgonistsReceptor, Serotonin, 5-HT2A

Autor:innen und Institutionen

  • Department of Chemistry, University of California, Davis, Davis, California95616, United States.
  • Department of Biochemistry & Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California95817, United States.
  • Institute for Psychedelics and Neurotherapeutics, University of California, Davis, Davis, California95616, United States.
  • Center for Neuroscience, University of California, Davis, Davis, California95618, United States.

ORCID-Profile: Cassandra J Hatzipantelis, David E Olson

Zitieren

APA

Hatzipantelis, C. J., & Olson, D. E. (2026). Gi Signaling Does Not Differentiate Hallucinogenic from Nonhallucinogenic 5-HT2A Receptor Agonists. ACS Chemical Neuroscience, 17(21), 3458-3461. https://doi.org/10.1021/acschemneuro.6c00743

Vancouver

Hatzipantelis CJ, Olson DE. Gi Signaling Does Not Differentiate Hallucinogenic from Nonhallucinogenic 5-HT2A Receptor Agonists. ACS Chemical Neuroscience. 2026;17(21):3458-3461. doi:10.1021/acschemneuro.6c00743

BibTeX
@article{Hatzipantelis2026,
  author = {Hatzipantelis, Cassandra J and Olson, David E},
  title = {Gi Signaling Does Not Differentiate Hallucinogenic from Nonhallucinogenic 5-HT2A Receptor Agonists},
  journal = {ACS Chemical Neuroscience},
  year = {2026},
  volume = {17},
  number = {21},
  pages = {3458--3461},
  doi = {10.1021/acschemneuro.6c00743}
}
Kostenlos starten →